Anand Rathi's Jigar Patel suggests Birlasoft, Natco Pharma, and GAEL as potential stocks for short-term profit due to identified favorable buying points. Meanwhile, the Nifty 50 and Bank Nifty indices show mixed directions, with significant levels of 23,100 for Nifty and 52,500 for Bank Nifty requiring confirmation for future trends.

Analysts suggest investing in Adani Power, Titan, Cummins India, Mankind Pharmaceuticals, and Arvind Ltd, due to their positive technical trends and sectoral performance. Expected price levels for these stocks are Rs 170 (Adani Power), Rs 4,180 (Titan), Rs 4,820 (Cummins India), Rs 2,250 (Mankind Pharma), and Rs 430 (Arvind Ltd).

The Nifty Healthcare index has slumped by 8% to 13,790, plummeting below its moving average, due to concerns about US tariffs. Sun Pharma may experience a 5% earnings decline in FY28, while companies like Aurobindo and Cipla find temporary relief but still face potential policy-related challenges. [Source: Business Standard]

GACM Technologies announced that their promoters have not pledged shares for the financial year ending March 31, 2026, as per SEBI regulations regarding substantial share acquisitions.

The Supreme Court has dismissed a stay request regarding Jaiprakash Associates' resolution, paving the way for its progression with involvement from Vedanta and Adani.

Trent's shares soared by more than 3%, leading the Nifty index, following a robust Q4 performance report, suggesting improved business health.

Analysts recommend investing in Kakatiya Cement, Bliss GVS Pharma, and Arvind as market volatility offers potential buy opportunities. Suggested price targets are Rs 105-120 for Kakatiyas, Rs 245 for Bliss GVS, and Rs 430 for Arvind. For risk management, it's advised to set stop-losses.

Major Indian corporations experienced a combined loss of approximately ₹65k crore in market value this week, with Airtel bearing the brunt of losses totaling ₹29,993 crore. The broader market faced challenges from both global and domestic issues, but Reliance Industries managed to maintain the highest valuation at around ₹18.28 lakh crore.

Tech funding in India saw a significant 23% drop in the fiscal year 2026, reaching approximately $10.9 billion, as reported by Tracxn. However, this figure represents an 13% increase compared to $9.7 billion in FY24, indicating a slight recovery from previous lows.

Angel One's Osho Krishan suggests considering investments in Hindustan Zinc and Chennai Petroleum due to positive technical indicators and promising setups. However, the Indian stock market took a dip on April 2 amidst global tensions, with Nifty 50 and Sensex falling, while FPIs sold off assets worth Rs. 83.3B, offset slightly by DIIs' purchases of Rs. 71.7B.

"Latent View Analytics plans to invest $3 million into Healtheon AI, marking a significant strategic move to strengthen their AI capabilities."

Airfare costs for domestic travel remain stable despite a 25% increase in ATF prices, as airlines absorb some of the additional crude oil costs. However, international ticket prices, particularly on western routes, might continue to rise following a recent doubling and potential further impacts from geopolitical events like the Iran conflict.

Sagility Ltd presented its strategic plans for AI-integrated US healthcare at a recent investor meeting. The company demonstrated resilient growth despite economic pressures, leadership in advanced AI solutions for healthcare, and longstanding relationships with major US health insurers.

Latent View Analytics experienced a significant investment today as Junomoneta Finsol purchased approximately 13.42 million shares at ₹291.1 each on the National Stock Exchange. This purchase suggests a confidence boost in the company's future prospects.

HSBC adjusts target prices for Indian banks due to escalating Iran conflict risks and mounting asset pressures. Major players like HDFC Bank, ICICI, Axis, SBI, Bajaj Finance face reduced targets, while LIC Housing is identified as a defensive choice amid these uncertainties.

United Spirits Ltd. conducted a significant block trade of over 171,000 shares worth approximately INR 21.21 crore on the NSE, with each share being sold for INR 1240.

Shipyard stocks experienced a notable surge on April 1, with GRSE reporting a remarkable turnover of ₹6,400 crore in the fiscal year 2025-26. This increase can be attributed to the inclusion of Cochin Shipyard in F&O and Mazagon Dock's consistent performance.

Marksans Pharma has received FDA approval for its Benzonatate capsules, enabling them to introduce this medication into the U.S. market with two available strengths: 100 mg and 200 mg.

Bernstein anticipates Zomato and Swiggy to enhance profitability by raising fees, potentially increasing EBITDA per order by 4-9%. The valuation discrepancy between Zomato ($12-14B) and Swiggy ($4-5B) in quick commerce suggests potential consolidation could narrow the gap.

Sammaan Capital is strategizing to break into the top three Non-Banking Financial Companies (NBFC) rankings by Assets Under Management (AUM) by FY29. In a move to expand its portfolio, India's Housing Finance Corporation (IHC) has recently invested 8,850 crores, securing a 63.3% stake.